CDD in Chemical & Engineering News

C&EN_logo smThe June 24 Issue of Chemical & Engineering News (C&E News) explored the benefits of using collaborative software within the drug discovery industry. The article started with a description of the current, growing need to manage and share data between drug firms, academic labs, and CROs.

Around the all important topic of security, Michael Elliott (CEO at Atrium Research & Consulting) mentioned in the article “I would argue that cloud applications have better protection than most companies have behind their firewalls.”

This timely C&E News article highlighted the current trends with big pharmas and big vendors in the drug discovery informatics space. Phyllis Post, executive director of IT account management at Merck was quoted stating that “I don’t believe the cultural revolution in sharing information in the scientific sector has been overstated.”

With regards specifically to CDD, the article mentioned:

Collaborative Drug Discovery (CDD), a supplier of chemistry and biology database software that supports research partnerships, was spun off from Eli Lilly & Co. nine years ago as part of the same program that produced Inno­Centive, an online “open innovation” resource that counts as an early instance of crowdsourcing in pharmaceutical research. The National Institutes of Health uses the CDD product CDD Vault to support collaboration among companies working on the NIH Blueprint for Neuroscience Research, a consortium of industry and academic research labs investigating how individual brain cells and neural circuits interact.

The full article can be accessed online with a subscription to C&E News using an ACS member number to login here.